Physician profile
Breda Knott
NPI 1447743745
$2,968.14
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $102 · 2021: $1,691 · 2022: $514 · 2023: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,575.05 | 2020-2021 | |
| Cardiovascular Systems INC. | $275.43 | 2021-2022 | |
| Kci USA, INC. | $206.47 | 2019-2023 | Prevena, V.A.C. Dermatac |
| Tela Bio, INC. | $190.17 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $125.58 | 2022 | |
| Hologic Sales and Service, LLC | $120.77 | 2022 | |
| Innovation Technologies INC | $97.15 | 2023 | Irrisept |
| Zimmer Biomet Holdings, INC. | $82.74 | 2022 | |
| Convatec INC. | $67.40 | 2019 | |
| Baxter Healthcare | $66.43 | 2019 | |
| Kerecis Limited | $65.79 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Intuitive Surgical, INC. | $29.69 | 2023 | Da Vinci Surgical System |
| Cordis US Corp. | $29.54 | 2022 | |
| Innocoll Pharmaceuticals Limited | $24.45 | 2021 | |
| Pfizer INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breda Knott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.